Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury

Abad, 2002, Pituitary adenylate-cyclase-activating polypeptide expression in the immune system, Neuroimmunomodulation, 10, 177, 10.1159/000067180 Aikin, 2004, Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans, J Mol Med, 82, 389, 10.1007/s00109-004-0540-5 Arany, 2003, Cisplatin nephrotoxicity, Semin Nephrol, 23, 460, 10.1016/S0270-9295(03)00089-5 Arimura, 2006, Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury, Blood, 107, 661, 10.1182/blood-2005-03-1186 Arimura, 2006, Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38, Ann N Y Acad Sci, 1070, 1, 10.1196/annals.1317.093 Bonegio, 2002, Role of apoptosis in the pathogenesis of acute renal failure, Curr Opin Nephrol Hypertens, 11, 301, 10.1097/00041552-200205000-00006 Cummings, 2002, Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways, J Pharmacol Exp Ther, 302, 8, 10.1124/jpet.302.1.8 Cuvillier, 2001, Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells, Cell Death Differ, 8, 162, 10.1038/sj.cdd.4400793 Delgado, 2003, PACAP in immunity and inflammation, Ann N Y Acad Sci, 992, 141, 10.1111/j.1749-6632.2003.tb03145.x Delgado, 2004, VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells, FASEB J, 18, 1453, 10.1096/fj.04-1548fje Delgado, 1999, Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6, J Immunol, 162, 1200, 10.4049/jimmunol.162.2.1200 Faubel, 2004, Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis, Kidney Int, 66, 2202, 10.1111/j.1523-1755.2004.66010.x Grombacher, 1998, p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents, Oncogene, 17, 845, 10.1038/sj.onc.1202000 Harmar, 1998, International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide, Pharmacol Rev, 50, 265 Hegde, 2008, Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells, Cell Res, 18, 27, 10.1038/cr.2008.8 Ho, 2003, Transcriptional repression mediated by the p53 tumour suppressor, Cell Death Differ, 10, 404, 10.1038/sj.cdd.4401191 Jiang, 2008, Regulation and pathological role of p53 in cisplatin nephrotoxicity, J Pharmacol Exp Ther, 327, 300, 10.1124/jpet.108.139162 Jiang, 2009, Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway, Am J Physiol Renal Physiol, 296, F983, 10.1152/ajprenal.90579.2008 Jiang, 2006, Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis, Oncogene, 25, 4056, 10.1038/sj.onc.1209440 Jiang, 2004, Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity, Am J Physiol Renal Physiol, 287, F1140, 10.1152/ajprenal.00262.2004 Karamessinis, 2002, Proximal tubular epithelial cell integrins respond to high glucose by altered cell–matrix interactions and differentially regulate matrixin expression, Lab Invest, 82, 1081, 10.1097/01.LAB.0000022224.86237.31 Kaushal, 2001, Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells, Kidney Int, 60, 1726, 10.1046/j.1523-1755.2001.00026.x Kindt, 2008, Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure, FASEB J, 22, 510, 10.1096/fj.07-8882com Li, 2008, Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells, Am J Physiol Renal Physiol, 295, F82, 10.1152/ajprenal.00091.2008 Li, 2008, Myeloma light chains induce epithelial–mesenchymal transition in human renal proximal tubule epithelial cells, Nephrol Dial Transplant, 23, 860, 10.1093/ndt/gfm670 Li, 2008, Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases, Regul Pept, 145, 24, 10.1016/j.regpep.2007.09.012 Li, 2007, Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study, Peptides, 28, 1891, 10.1016/j.peptides.2007.05.002 Mihara, 2003, p53 has a direct apoptogenic role at the mitochondria, Mol Cell, 11, 577, 10.1016/S1097-2765(03)00050-9 Mitra, 2007, Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein, DNA Repair (Amst), 6, 461, 10.1016/j.dnarep.2006.10.010 Miyashita, 1995, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, 80, 293, 10.1016/0092-8674(95)90412-3 Miyata, 1989, Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells, Biochem Biophys Res Commun, 164, 567, 10.1016/0006-291X(89)91757-9 Molina, 2005, Renal ischemia/reperfusion injury: functional tissue preservation by anti-activated {beta}1 integrin therapy, J Am Soc Nephrol, 16, 374, 10.1681/ASN.2004070528 Molitoris, 2009, siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury, J Am Soc Nephrol, 10.1681/ASN.2008111204 Nakano, 2001, PUMA, a novel proapoptotic gene, is induced by p53, Mol Cell, 7, 683, 10.1016/S1097-2765(01)00214-3 Nony, 2003, Mechanisms of renal cell repair and regeneration after acute renal failure, J Pharmacol Exp Ther, 304, 905, 10.1124/jpet.102.035022 Oda, 2000, Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis, Science, 288, 1053, 10.1126/science.288.5468.1053 Oda, 2000, p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53, Cell, 102, 849, 10.1016/S0092-8674(00)00073-8 Pabla, 2008, ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis, J Biol Chem, 283, 6572, 10.1074/jbc.M707568200 Paller, 1997, Integrins and repair after acute renal injury, Kidney Int Suppl, 61, S52 Pearson, 2000, Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells, Clin Cancer Res, 6, 887 Peddi, 2006, The human apurinic/apyrimidinic endonuclease-1 suppresses activation of poly(adp-ribose) polymerase-1 induced by DNA single strand breaks, Toxicology, 224, 44, 10.1016/j.tox.2006.04.025 Pisegna, 1996, Differential signaling and immediate-early gene activation by four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R), Ann N Y Acad Sci, 805, 54, 10.1111/j.1749-6632.1996.tb17473.x Pisegna, 1996, Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C, J Biol Chem, 271, 17267, 10.1074/jbc.271.29.17267 Riera, 2001, The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response, Transplantation, 72, 1217, 10.1097/00007890-200110150-00006 Ruiz-Torres, 2005, The accumulation of extracellular matrix in the kidney: consequences on cellular function, J Nephrol, 18, 334 Sax, 2002, BID regulation by p53 contributes to chemosensitivity, Nat Cell Biol, 4, 842, 10.1038/ncb866 Seth, 2005, p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury, J Biol Chem, 280, 31230, 10.1074/jbc.M503305200 Sheikh-Hamad, 2004, Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney, Arch Toxicol, 78, 147, 10.1007/s00204-003-0521-4 Shenoy, 2001, beta1 Integrin–extracellular matrix protein interaction modulates the migratory response to chemokine stimulation, Biochem Cell Biol, 79, 399, 10.1139/o01-026 Srivenugopal, 2001, Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents, Clin Cancer Res, 7, 1398 Szakaly, 2008, Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion, J Mol Neurosci, 36, 89, 10.1007/s12031-008-9064-8 Tsuruya, 2008, Involvement of p53-transactivated Puma in cisplatin-induced renal tubular cell death, Life Sci, 83, 550, 10.1016/j.lfs.2008.08.002 Wei, 2007, Activation and involvement of p53 in cisplatin-induced nephrotoxicity, Am J Physiol Renal Physiol, 293, F1282, 10.1152/ajprenal.00230.2007 Wesierska-Gadek, 2004, In vivo activated caspase-3 cleaves PARP-1 in rat liver after administration of the hepatocarcinogen N-nitrosomorpholine (NNM) generating the 85kDa fragment, J Cell Biochem, 93, 774, 10.1002/jcb.20181 Yang, 2008, Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity, Cell Death Differ, 15, 530, 10.1038/sj.cdd.4402287 Yang, 2006, Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress, J Pharmacol Exp Ther, 319, 595, 10.1124/jpet.106.102236 Yano, 2007, Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin, Apoptosis, 12, 1901, 10.1007/s10495-007-0110-8 Yu, 2003, PUMA mediates the apoptotic response to p53 in colorectal cancer cells, Proc Natl Acad Sci U S A, 100, 1931, 10.1073/pnas.2627984100 Zaky, 2008, Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage, Nucleic Acids Res, 36, 1555, 10.1093/nar/gkm1173 Zeltzer, 2000, Diminished chemokine and cytokine-induced adhesion of CD4+ T cells to extracellular matrix ligands in patients with end-stage renal failure, Isr Med Assoc J, 2, 282 Zuk, 2002, Induction of a laminin isoform and alpha(3)beta(1)-integrin in renal ischemic injury and repair in vivo, Am J Physiol Renal Physiol, 283, F971, 10.1152/ajprenal.00176.2002